HUGE 8K filing fresh out On May 8, 2020, Therapeutic Solutions International, Inc. released the following headline in a press release “Therapeutic Solutions International Initiates 500 Volunteer COVID-19 Prevention Clinical Trial Using QuadraMune™”. The new clinical trial has been granted ClinicalTrials.gov Identifier: NCT04421391 on Friday June 5th. On June 9, 2020 the Protocol Registration and Results System (PRS) has posted our registration and is available on the Federal Clinical Trial registry at this link https://clinicaltrials.gov/ct2/show/NCT04421391